A Combination of Pioglitazone and Leptin as Treatment for the HAART -Induced Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Trial Profile

A Combination of Pioglitazone and Leptin as Treatment for the HAART -Induced Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Mar 2017

At a glance

  • Drugs Leptin (Primary) ; Metformin (Primary) ; Pioglitazone (Primary)
  • Indications Hypercholesterolaemia; Hypertriglyceridaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Oct 2009 Planned end date added to 1 Jul 2009 as reported by ClinicalTrials.gov.
    • 20 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top